PathAI provides artificial intelligence and digital pathology solutions designed to improve workflow and operational efficiency in pathology laboratories globally. The company operates AISight, a cloud-native digital pathology image management platform that supports laboratory workflows, clinical operations, and research initiatives.
The company serves multiple segments within life sciences and healthcare. Its biopharma services address the needs of pharmaceutical and biotechnology organisations, whilst its anatomic pathology and clinical development solutions support healthcare systems and research institutions. PathAI maintains a network of over 450 pathologists - both proprietary and crowd-sourced - and has leveraged more than 32.5 million annotations to train and validate its AI models. The company maintains a substantial archive of pathology data to support its operations and research activities.
PathAI's technical foundation combines expertise in artificial intelligence, computational pathology, cloud infrastructure, and medical domain knowledge. The company's capabilities include AI model development and validation, crowd-sourced annotation management, and precision pathology tools designed to integrate into existing laboratory operations.
